CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer have?
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer has 521 citations in the OpenAlex counts ScholarIQ stores.
When was CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer published?
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer has 2021 year in the ScholarIQ index.
What is the open-access status of CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer?
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer has bronze oa status in the ScholarIQ index.
What is the DOI of CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer?
The DOI for CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer is on the source record.
What is the PMID of CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer?
The PMID for CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer is on the source record.
What is the OpenAlex record for CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer?
The OpenAlex for CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer is on the source record.